American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
University of Louisville
Study ID
NCT02674100
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Registry — OTHER

Study Details

The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.

Key Dates

Start date
Jan 31, 2016
Status verified
Dec 2024
Primary completion
Jan 31, 2030
Completion
Jan 31, 2030

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Adverse Events [ Time Frame: Up to 5 years ]

Central Contacts

Locations (11)

FacilityCityStateZIPSite coordinators
University of Alabama BirminghamBirminghamAlabama35233
John Christein, MD
[email protected]
University of California San DiegoSan DiegoCalifornia92093
Rebekah White, MD
[email protected]
University of ColoradoDenverColorado80309
Ana Gleisner
[email protected]
University of South FloridaTampaFlorida33620
Rachel Karlnoski
[email protected]
Augusta UniversityAugustaGeorgia30912
Edward Kruse, MD
[email protected]
University of LouisvilleLouisvilleKentucky40202
Robert Martin, MD (PRINCIPAL_INVESTIGATOR)
Johns Hopkins HospitalBaltimoreMaryland21218
Matthew Weiss, MD
[email protected]
Atlantic HealthMillburnNew Jersey07041
Kai Bickenbach, MD
[email protected]
Northwell Health Cancer InstituteLake SuccessNew York11042
Gary Deutsch, MD
[email protected]
Gibbs Cancer Research, Spartanburg Regional Healthcare SystemSpartanburgSouth Carolina29303
Heather Farmer
[email protected]
Methodist Digestive InstituteDallasTexas75203
Alejandro Mejia, MD
[email protected]

Find similar trials in Birmingham, AL

By condition
Pancreatic cancer
By specialty
OncologyGI oncology
By research site
University of Alabama Birmingham· Birmingham, ALUniversity of California San Diego· San Diego, CAUniversity of Colorado· Denver, COUniversity of South Florida· Tampa, FLAugusta University· Augusta, GAUniversity of Louisville· Louisville, KY

Related Studies